Lactobacillus plant arum strain, polysaccharides derived from strain, and use thereof
AssigneeImmunobiome Inc.
InventorsSin-Hyeog Im, Garima Sharma, Sun-Hee Park, Amit Sharma
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunobiome Inc.
InventorsSin-Hyeog Im, Garima Sharma, Sun-Hee Park, Amit Sharma
Estimating the term…
The present invention relates to a novel Lactobacillus plantarum IMB19 strain, polysaccharides derived from the strain, and a use thereof. A novel Lactobacillus plantarum IMB19 strain and polysaccharides derived from the strain of the present invention exhibit an excellent CD8+T cell activity stimulating ability and Treg cell inhibitory activity, and stimulate and improve an antitumor immune response through various mechanisms such as increased macrophage infiltration in CPS tumors and differentiation and reprogramming of macrophages into an inflammatory phenotype (M1). Therefore, a strain and polysaccharides derived from the strain of the present invention can be effectively used for immune regulation, especially immune boosting, in a subject, and can inhibit tumor growth by inducing and enhancing an antitumor immune response. A novel strain and polysaccharides derived from the strain of the present invention are useful in the prevention, alleviation or treatment of such as tumors, infectious diseases and various immune diseases that are the cause of or symptom of immune dysfunction.
A method of immune modulation, comprising administering a Lactobacillus plantarum IMB19 strain having accession number KCTC 14337BP or a capsular polysaccharide derived from the strain to a subject.
A method of immune modulation comprising administering a polysaccharide represented by Formula I below to a subject:
A method of producing inflammatory T cells, comprising:
A method of producing M1-phenotype macrophages, comprising:
Dependencies are inferred from the claim text.